Works matching DE "IMMUNE checkpoint proteins"
Results: 4917
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Development of Platinum Complexes for Tumor Chemoimmunotherapy.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 10, p. 1, doi. 10.1002/chem.202302948
- By:
- Publication type:
- Article
Design of Mitoxantrone‐Loaded Biomimetic Nanocarrier with Sequential Photothermal/Photodynamic/Chemotherapy Effect for Synergized Immunotherapy.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 40, p. 1, doi. 10.1002/adfm.202302231
- By:
- Publication type:
- Article
Ferroptosis and Pyroptosis Co‐Activated Nanomodulator for "Cold" Tumor Immunotherapy and Lung Metastasis Inhibition.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 37, p. 1, doi. 10.1002/adfm.202211698
- By:
- Publication type:
- Article
Metabolic Regulation of Tumor Microenvironment with Biohybrid Bacterial Bioreactor for Enhanced Cancer Chemo‐Immunotherapy.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 35, p. 1, doi. 10.1002/adfm.202302728
- By:
- Publication type:
- Article
A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic Immunotherapy.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 16, p. 1, doi. 10.1002/adfm.202214499
- By:
- Publication type:
- Article
Bioresponsive Self‐Reinforcing Sericin/Silk Fibroin Hydrogel for Relieving the Immune‐Related Adverse Events in Tumor Immunotherapy.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 15, p. 1, doi. 10.1002/adfm.202213867
- By:
- Publication type:
- Article
Nanoagonist‐Mediated GSDME‐Dependent Pyroptosis Remodels the Inflammatory Microenvironment for Tumor Photoimmunotherapy.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 6, p. 1, doi. 10.1002/adfm.202200811
- By:
- Publication type:
- Article
A Triple‐Kill Strategy for Tumor Eradication Reinforced by Metal‐Phenolic Network Nanopumps.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 21, p. 1, doi. 10.1002/adfm.202113168
- By:
- Publication type:
- Article
Oligomycin A Induces Apoptosis‐to‐Pyroptosis Switch against Melanoma with Sensitized Immunotherapy.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 4, p. 1, doi. 10.1002/adfm.202106332
- By:
- Publication type:
- Article
An Integrated Nanoaircraft Carrier Modulating Antitumor Immunity to Enhance Immune Checkpoint Blockade Therapy.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 48, p. 1, doi. 10.1002/adfm.202106123
- By:
- Publication type:
- Article
A Checkpoint‐Regulatable Immune Niche Created by Injectable Hydrogel for Tumor Therapy.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 37, p. 1, doi. 10.1002/adfm.202104630
- By:
- Publication type:
- Article
Reshaping Antitumor Immunity with Chemo‐Photothermal Integrated Nanoplatform to Augment Checkpoint Blockade‐Based Cancer Therapy.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 28, p. 1, doi. 10.1002/adfm.202100437
- By:
- Publication type:
- Article
Combining Photothermal‐Photodynamic Therapy Mediated by Nanomaterials with Immune Checkpoint Blockade for Metastatic Cancer Treatment and Creation of Immune Memory.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 29, p. 1, doi. 10.1002/adfm.202010777
- By:
- Publication type:
- Article
Synergy of Immunostimulatory Genetherapy with Immune Checkpoint Blockade Motivates Immune Response to Eliminate Cancer.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 22, p. 1, doi. 10.1002/adfm.202100715
- By:
- Publication type:
- Article
Tumor necrosis factor superfamily signaling: life and death in cancer.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 4, p. 1137, doi. 10.1007/s10555-024-10206-6
- By:
- Publication type:
- Article
Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 155, doi. 10.1007/s10555-023-10141-y
- By:
- Publication type:
- Article
Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 597, doi. 10.1007/s10555-023-10139-6
- By:
- Publication type:
- Article
Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 837, doi. 10.1007/s10555-021-09981-3
- By:
- Publication type:
- Article
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.
- Published in:
- World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05392-5
- By:
- Publication type:
- Article
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 4, p. 647, doi. 10.1007/s00401-023-02617-6
- By:
- Publication type:
- Article
Nothing Great Comes Without Its Risks: A Rare Case of Pembrolizumab-Induced Hypophysitis.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 1, p. 1, doi. 10.1210/jcemcr/luad135
- By:
- Publication type:
- Article
Marked Hypoleptinemia Precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 2, p. 1, doi. 10.1210/jcemcr/luad025
- By:
- Publication type:
- Article
New Insight into the Role of AhR in Lung Carcinogenesis.
- Published in:
- Biochemistry (00062979), 2022, v. 87, n. 11, p. 1219, doi. 10.1134/S0006297922110013
- By:
- Publication type:
- Article
Coffee extracts and caffeine upregulate the expression of the immune checkpoint factors, PD‑1 and PD‑L1.
- Published in:
- International Journal of Functional Nutrition, 2024, v. 5, n. 1, p. N.PAG, doi. 10.3892/ijfn.2024.36
- By:
- Publication type:
- Article
CAR-T-Cell Therapy Based on Immune Checkpoint Modulation in the Treatment of Hematologic Malignancies.
- Published in:
- Cell Transplantation, 2024, v. 33, p. 1, doi. 10.1177/09636897241293964
- By:
- Publication type:
- Article
The New T Cell Subset Opens a New Realm for Tumor Immunotherapy.
- Published in:
- Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221138037
- By:
- Publication type:
- Article
ASSOCIAÇÃO DO POLIMORFISMO DO GENE LIGANTE DE MORTE PROGRAMADA-1 (PD-L1) COM O CÂNCER DE MAMA.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2024, v. 17, n. 4, p. 1, doi. 10.54751/revistafoco.v17n4-104
- By:
- Publication type:
- Article
Single-cell RNA sequencing reveals tumor heterogeneity in small cell neuroendocrine cervical carcinoma.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07605-y
- By:
- Publication type:
- Article
Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry.
- Published in:
- Turkish Journal of Medical Sciences, 2024, v. 54, n. 4, p. 735, doi. 10.55730/1300-0144.5843
- By:
- Publication type:
- Article
Investigation of the relationship between immune checkpoints and mismatch repair deficiency in recurrent and nonrecurrent glioblastoma.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 4, p. 1800, doi. 10.3906/sag-2010-166
- By:
- Publication type:
- Article
Crystal structure of the human LAG-3–HLA-DR1–peptide complex.
- Published in:
- Science Immunology, 2024, v. 9, n. 102, p. 1, doi. 10.1126/sciimmunol.ads5122
- By:
- Publication type:
- Article
Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity.
- Published in:
- Science Immunology, 2024, v. 9, n. 101, p. 1, doi. 10.1126/sciimmunol.adp7302
- By:
- Publication type:
- Article
The redox sensor KEAP1 facilitates adaptation of T cells to chronic antigen stimulation by preventing hyperactivation.
- Published in:
- Science Immunology, 2024, v. 9, n. 101, p. 1, doi. 10.1126/sciimmunol.adk2954
- By:
- Publication type:
- Article
Expansion of tumor-reactive CD8<sup>+</sup> T cell clonotypes occurs in the spleen in response to immune checkpoint blockade.
- Published in:
- Science Immunology, 2024, v. 9, n. 99, p. 1, doi. 10.1126/sciimmunol.adi3487
- By:
- Publication type:
- Article
LRIG1 engages ligand VISTA and impairs tumor-specific CD8<sup>+</sup> T cell responses.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adi7418
- By:
- Publication type:
- Article
TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adi5374
- By:
- Publication type:
- Article
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells.
- Published in:
- Science Immunology, 2024, v. 9, n. 93, p. 1, doi. 10.1126/sciimmunol.adf2223
- By:
- Publication type:
- Article
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+ </sup>T-myeloid cell networks in melanoma.
- Published in:
- Science Immunology, 2024, v. 9, n. 92, p. 1, doi. 10.1126/sciimmunol.adg7995
- By:
- Publication type:
- Article
Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
- Published in:
- Science Immunology, 2022, v. 7, n. 75, p. 1, doi. 10.1126/sciimmunol.abn9644
- By:
- Publication type:
- Article
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
- Published in:
- Science Immunology, 2022, v. 7, n. 75, p. 1, doi. 10.1126/sciimmunol.abn0704
- By:
- Publication type:
- Article
CD39<sup>+</sup> tissue-resident memory CD8<sup>+</sup> T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer.
- Published in:
- Science Immunology, 2022, v. 7, n. 74, p. 1, doi. 10.1126/sciimmunol.abn8390
- By:
- Publication type:
- Article
Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells.
- Published in:
- Science Immunology, 2022, v. 7, n. 74, p. 1, doi. 10.1126/sciimmunol.abj9123
- By:
- Publication type:
- Article
Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy.
- Published in:
- Science Immunology, 2022, v. 7, n. 70, p. 1, doi. 10.1126/sciimmunol.abk1692
- By:
- Publication type:
- Article
The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity.
- Published in:
- Science Immunology, 2021, v. 6, n. 65, p. 1, doi. 10.1126/sciimmunol.abf4034
- By:
- Publication type:
- Article
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8<sup>+</sup> T cell clone size and cytotoxicity.
- Published in:
- Science Immunology, 2021, v. 6, n. 64, p. 1, doi. 10.1126/sciimmunol.abj8825
- By:
- Publication type:
- Article
A battle between two biological singularities: Immune response vs. cancer.
- Published in:
- Biophysics & Physicobiology, 2024, v. 21, p. 1, doi. 10.2142/biophysico.bppb-v21.s006
- By:
- Publication type:
- Article
On a discrete model of tumour–immune system interactions with blockade of immune checkpoints.
- Published in:
- Journal of Difference Equations & Applications, 2022, v. 28, n. 1, p. 73, doi. 10.1080/10236198.2021.2023136
- By:
- Publication type:
- Article
Bioactive Compounds from the Mushroom-Forming Fungus Chlorophyllum molybdites.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 596, doi. 10.3390/antibiotics12030596
- By:
- Publication type:
- Article
Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1306, doi. 10.3390/vaccines12121306
- By:
- Publication type:
- Article